Impact of statins on atherosclerotic plaque

Area of Science:

• Cardiology
• Pharmacology

Background:

• Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are primary agents for reducing cardiovascular events.
• Their benefit is linked to the degree of low-density lipoprotein cholesterol reduction.
• Emerging evidence suggests statins possess non-lipid-modifying properties contributing to clinical outcomes.

Purpose of the Study:

• To investigate the extent to which statins' non-lipid-modifying properties impact atherosclerotic plaque in humans.
• To evaluate the role of advanced imaging modalities in monitoring these effects.

Main Methods:

• Utilizing various imaging modalities to assess atherosclerotic plaque extent and composition.
• Correlating imaging findings with statin therapy and clinical outcomes.

Main Results:

• Imaging studies demonstrate statins' impact on atherosclerotic plaque.
• Evidence suggests both lipid-lowering and non-lipid-modifying effects contribute to plaque stabilization and regression.

Conclusions:

• Statins offer significant cardiovascular benefits, primarily through low-density lipoprotein cholesterol reduction.
• Non-lipid-modifying effects of statins play a role in managing atherosclerosis.
• Advanced imaging techniques are crucial for visualizing and understanding statin's comprehensive impact on plaque.